Claude Roth
6Patents
2h-index
10Co-inventors
48Inventor score
Filing activity: Jun 7, 1995 → Mar 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10316066B2 | Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US6074637A | Cellular composition for the treatment of human or animal organisms | Human Necessities | 2 | Expired |
| US11872276B2 | Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US11305003B2 | Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US6090378A | Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors | Chemistry; Metallurgy | 0 | Expired |
| US11034730B2 | Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.